CWG
C WorldWide Group Portfolio holdings
AUM
$7.38B
This Quarter Return
-0.04%
1 Year Return
+18.35%
3 Year Return
+71.53%
5 Year Return
+105.42%
10 Year Return
+360.65%
AUM
$8.06B
AUM Growth
+$8.06B
(-1.7%)
Cap. Flow
+$63.1M
Cap. Flow
% of AUM
0.78%
Top 10 Holdings %
Top 10 Hldgs %
60.05%
Holding
96
New
5
Increased
15
Reduced
36
Closed
4
Top Buys
| 1 |
Progressive
PGR
|
$350M |
| 2 |
Republic Services
RSG
|
$230M |
| 3 |
Royalty Pharma
RPRX
|
$13.9M |
| 4 |
HDFC Bank
HDB
|
$9.06M |
| 5 |
TSMC
TSM
|
$8.3M |
Top Sells
| 1 |
Costco
COST
|
$376M |
| 2 |
Thermo Fisher Scientific
TMO
|
$21.5M |
| 3 |
Visa
V
|
$15.1M |
| 4 |
Illumina
ILMN
|
$10.4M |
| 5 |
Outset Medical
OM
|
$10.3M |
Sector Composition
| 1 | Financials | 27.49% |
| 2 | Technology | 17.2% |
| 3 | Healthcare | 13.44% |
| 4 | Industrials | 11.76% |
| 5 | Consumer Discretionary | 9.35% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
26
DexCom
DXCM
$29.5B
| $30.7M | 0.38% | 449,000 +100,000 | +29% | +$6.83M |
|
27
Insulet
PODD
$23.9B
| $29.4M | 0.36% | 111,908 -36,000 | -24% | -$9.45M |
|
28
Edwards Lifesciences
EW
$47.8B
| $28.9M | 0.36% | 398,318 -60,235 | -13% | -$4.37M |
|
29
Natera
NTRA
$23.1B
| $28.3M | 0.35% | 200,000 | – | – |
|
30
Vertex Pharmaceuticals
VRTX
$100B
| $26.2M | 0.33% | 54,057 -13,500 | -20% | -$6.55M |
|
31
Insmed
INSM
$28.8B
| $24.5M | 0.3% | 321,110 -22,000 | -6% | -$1.68M |
|
32
Medtronic
MDT
$119B
| $22.9M | 0.28% | 255,000 -35,000 | -12% | -$3.15M |
|
33
Tencent Music
TME
$37.8B
| $21.4M | 0.27% | 1,481,606 -18,285 | -1% | -$263K |
|
34
Service Corp International
SCI
$11.1B
| $20.1M | 0.25% | 250,917 +600 | +0.2% | +$48.1K |
|
35
MakeMyTrip
MMYT
$9.4B
| $19.7M | 0.24% | 200,964 -77,609 | -28% | -$7.6M |
|
36
Penumbra
PEN
$10.6B
| $19.3M | 0.24% | 72,000 -25,000 | -26% | -$6.69M |
|
37
KE Holdings
BEKE
$20.8B
| $19.2M | 0.24% | 957,848 -11,846 | -1% | -$238K |
|
38
Mercado Libre
MELI
$125B
| $17.3M | 0.21% | 8,843 -218 | -2% | -$425K |
|
39
BioMarin Pharmaceuticals
BMRN
$11.2B
| $16.8M | 0.21% | 237,851 -66,000 | -22% | -$4.67M |
|
40
Zai Lab
ZLAB
$3.68B
| $16.6M | 0.21% | 460,000 -40,000 | -8% | -$1.45M |
|
41
Sarepta Therapeutics
SRPT
$1.78B
| $16M | 0.2% | 250,329 +60,000 | +32% | +$3.83M |
|
42
Glaukos
GKOS
$5.5B
| $16M | 0.2% | 162,212 | – | – |
|
43
Infosys
INFY
$69.7B
| $15.9M | 0.2% | 870,327 +17,358 | +2% | +$317K |
|
44
Krystal Biotech
KRYS
$4.27B
| $15.5M | 0.19% | 85,809 -20,000 | -19% | -$3.61M |
|
45
Verisk Analytics
VRSK
$37.5B
| $15.1M | 0.19% | 50,820 | – | – |
|
46
Synopsys
SNPS
$112B
| $14.7M | 0.18% | 34,303 +405 | +1% | +$174K |
|
47
MSCI
MSCI
$43.9B
| $14.1M | 0.17% | 24,908 | – | – |
|
48
Tyler Technologies
TYL
$24.4B
| $13.9M | 0.17% | 23,982 | – | – |
|
|
49
Royalty Pharma
RPRX
$15.6B
| $13.9M | 0.17% | +445,838 | New | +$13.9M |
|
50
Waters Corp
WAT
$18B
| $13.8M | 0.17% | 37,496 | – | – |
|